第一作者单位:[1]Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, 169 Donghu Rd, Wuhan 430072, Peoples R China[2]Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China[3]Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China[4]Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
通讯作者:
通讯机构:[1]Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, 169 Donghu Rd, Wuhan 430072, Peoples R China[2]Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China[3]Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China[4]Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
Zhou Feng,Liu Ye-Mao,Xie Jing,et al.Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality[J].HYPERTENSION.2020,76(2):E15-E17.doi:10.1161/HYPERTENSIONAHA.120.15622.
APA:
Zhou, Feng,Liu, Ye-Mao,Xie, Jing,Li, Haomiao,Lei, Fang...&Li, Hongliang.(2020).Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.HYPERTENSION,76,(2)
MLA:
Zhou, Feng,et al."Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality".HYPERTENSION 76..2(2020):E15-E17